
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2222-2227.DOI: 10.12114/j.issn.1007-9572.2024.0309
Special Issue: 高血压最新文章合辑; 心血管最新文章合辑; 神经/行为/心理最新文章合辑
• Article • Previous Articles Next Articles
Received:2024-05-10
Revised:2024-09-10
Published:2025-06-20
Online:2025-04-25
Contact:
YANG Li
通讯作者:
杨莉
作者简介:作者贡献:
何燕提出主要研究目标,负责撰写并修订论文;崔赛仙负责研究的构思与设计;胡阳、倪晴负责研究的实施;甘露路、代安妮进行数据的收集与整理;刘茜进行统计学处理;刘师节进行图、表的绘制与展示;杨莉负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0309
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI[M(P25,P75),kg/m2] | 腹围( | HB( | RBC( | FPG[M(P25,P75),mmol/L] |
|---|---|---|---|---|---|---|---|---|
| 轻度组 | 103 | 61/42 | 52.52±11.68 | 24.02(22.46,26.49) | 89.14±10.86 | 153.41±17.23 | 4.99±0.51 | 5.24(4.79,5.74) |
| 中度组 | 187 | 133/54 | 52.74±12.63 | 25.10(23.51,27.70)a | 94.01±11.10a | 154.10±17.36 | 5.03±0.54 | 5.34(4.91,6.03) |
| 重度组 | 203 | 151/52ab | 52.04±12.27 | 27.71(25.05,30.07)ab | 98.99±9.39ab | 154.64±16.55 | 5.11±0.59 | 5.25(4.88,6.16) |
| 检验统计量值 | 7.211c | 0.161 | 61.621d | 18.862 | 0.164 | 1.590 | 2.362d | |
| P值 | 0.027 | 0.851 | <0.001 | <0.001 | 0.849 | 0.205 | 0.307 | |
| 组别 | ALT[M(P25,P75),U/L] | AST[M(P25,P75),U/L] | eGFR[ | UA( | TC( | LDL-C( | HDL-C( | TG[M(P25,P75),mmol/L] |
| 轻度组 | 23(18,33) | 22(18,28) | 93.75±22.40 | 374.44±93.62 | 4.81±0.99 | 2.92±0.83 | 1.17±0.27 | 1.51(1.08,2.46) |
| 中度组 | 25(16,40) | 21(18,26) | 96.16±19.46 | 392.35±109.02 | 4.63±0.97 | 2.81±0.75 | 1.08±0.27a | 1.81(1.27,2.55) |
| 重度组 | 27(20,43)ab | 23(19,28) | 94.25±22.08 | 412.28±94.34ab | 4.49±0.95a | 2.72±0.78 | 1.02±0.23a | 1.89(1.28,2.65) |
| 检验统计量值 | 6.056d | 2.654d | 0.545 | 4.681 | 3.464 | 2.091 | 11.138 | 5.646d |
| P值 | 0.048 | 0.265 | 0.451 | 0.010 | 0.032 | 0.125 | <0.001 | 0.059 |
| 组别 | K( | Na( | 24 h尿钠排泄量( | 24 h尿钾( | 24 h尿钠钾比( | 24 hUALB[M(P25,P75),g/24 h] | 24 h估测摄盐量( | |
| 轻度组 | 4.07±0.41 | 140.72±2.58 | 158.58±51.83 | 40.59±13.65 | 4.28±1.82 | 0.16(0.13,0.23) | 9.24±3.03 | |
| 中度组 | 3.99±0.40 | 140.92±2.19 | 177.98±67.29a | 44.19±18.94 | 4.41±1.78 | 0.19(0.14,0.25)a | 10.41±3.91 a | |
| 重度组 | 3.96±0.40 | 140.82±2.64 | 198.85±67.27ab | 46.19±18.47ab | 4.69±1.77 | 0.22(0.15,0.31)ab | 11.63±3.93 ab | |
| 检验统计量值 | 2.578 | 0.196 | 13.317 | 3.147 | 2.177 | 15.282d | 13.320 | |
| P值 | 0.077 | 0.822 | <0.001 | 0.044 | 0.144 | <0.001 | <0.001 |
Table 1 Comparison of clinical data among three groups of patients with OSA-associated hypertension
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI[M(P25,P75),kg/m2] | 腹围( | HB( | RBC( | FPG[M(P25,P75),mmol/L] |
|---|---|---|---|---|---|---|---|---|
| 轻度组 | 103 | 61/42 | 52.52±11.68 | 24.02(22.46,26.49) | 89.14±10.86 | 153.41±17.23 | 4.99±0.51 | 5.24(4.79,5.74) |
| 中度组 | 187 | 133/54 | 52.74±12.63 | 25.10(23.51,27.70)a | 94.01±11.10a | 154.10±17.36 | 5.03±0.54 | 5.34(4.91,6.03) |
| 重度组 | 203 | 151/52ab | 52.04±12.27 | 27.71(25.05,30.07)ab | 98.99±9.39ab | 154.64±16.55 | 5.11±0.59 | 5.25(4.88,6.16) |
| 检验统计量值 | 7.211c | 0.161 | 61.621d | 18.862 | 0.164 | 1.590 | 2.362d | |
| P值 | 0.027 | 0.851 | <0.001 | <0.001 | 0.849 | 0.205 | 0.307 | |
| 组别 | ALT[M(P25,P75),U/L] | AST[M(P25,P75),U/L] | eGFR[ | UA( | TC( | LDL-C( | HDL-C( | TG[M(P25,P75),mmol/L] |
| 轻度组 | 23(18,33) | 22(18,28) | 93.75±22.40 | 374.44±93.62 | 4.81±0.99 | 2.92±0.83 | 1.17±0.27 | 1.51(1.08,2.46) |
| 中度组 | 25(16,40) | 21(18,26) | 96.16±19.46 | 392.35±109.02 | 4.63±0.97 | 2.81±0.75 | 1.08±0.27a | 1.81(1.27,2.55) |
| 重度组 | 27(20,43)ab | 23(19,28) | 94.25±22.08 | 412.28±94.34ab | 4.49±0.95a | 2.72±0.78 | 1.02±0.23a | 1.89(1.28,2.65) |
| 检验统计量值 | 6.056d | 2.654d | 0.545 | 4.681 | 3.464 | 2.091 | 11.138 | 5.646d |
| P值 | 0.048 | 0.265 | 0.451 | 0.010 | 0.032 | 0.125 | <0.001 | 0.059 |
| 组别 | K( | Na( | 24 h尿钠排泄量( | 24 h尿钾( | 24 h尿钠钾比( | 24 hUALB[M(P25,P75),g/24 h] | 24 h估测摄盐量( | |
| 轻度组 | 4.07±0.41 | 140.72±2.58 | 158.58±51.83 | 40.59±13.65 | 4.28±1.82 | 0.16(0.13,0.23) | 9.24±3.03 | |
| 中度组 | 3.99±0.40 | 140.92±2.19 | 177.98±67.29a | 44.19±18.94 | 4.41±1.78 | 0.19(0.14,0.25)a | 10.41±3.91 a | |
| 重度组 | 3.96±0.40 | 140.82±2.64 | 198.85±67.27ab | 46.19±18.47ab | 4.69±1.77 | 0.22(0.15,0.31)ab | 11.63±3.93 ab | |
| 检验统计量值 | 2.578 | 0.196 | 13.317 | 3.147 | 2.177 | 15.282d | 13.320 | |
| P值 | 0.077 | 0.822 | <0.001 | 0.044 | 0.144 | <0.001 | <0.001 |
| 组别 | 例数 | AHI[M(P25,P75),次/h] | LSaO2[M(P25,P75),%] | MSaO2[M(P25,P75),%] | 24 hMSBP( | 24 hMDBP( | dMSBP( | dMDBP( | nMSBP( | nMDBP( |
|---|---|---|---|---|---|---|---|---|---|---|
| 轻度组 | 103 | 10.20(7.40,12.90) | 80.00(78.50,86.00) | 93.00(91.50,94.00) | 131±15 | 84±12 | 133±16 | 85±12 | 127±16 | 80±12 |
| 中度组 | 187 | 22.30(18.83,26.48)a | 77.00(71.50,81.25)a | 90.00(87.00,93.00)a | 133±14 | 84±11 | 135±15 | 85±12 | 128±16 | 80±12 |
| 重度组 | 203 | 45.60(40.40,63.50)ab | 75.00(65.00,79.00)ab | 90.00(87.00,92.00)a | 135±18a | 86±13 | 136±18 | 87±13 | 130±19ab | 82±14 |
| F(H)值 | 414.811c | 73.117c | 61.436c | 1.522 | 1.823 | 1.222 | 1.272 | 1.640 | 1.006 | |
| P值 | <0.001 | <0.001 | <0.001 | 0.220 | 0.163 | 0.295 | 0.281 | 0.045 | 0.367 |
Table 2 Comparison of PSG and dynamic blood pressure data among three groups of patients with OSA-associated hypertension
| 组别 | 例数 | AHI[M(P25,P75),次/h] | LSaO2[M(P25,P75),%] | MSaO2[M(P25,P75),%] | 24 hMSBP( | 24 hMDBP( | dMSBP( | dMDBP( | nMSBP( | nMDBP( |
|---|---|---|---|---|---|---|---|---|---|---|
| 轻度组 | 103 | 10.20(7.40,12.90) | 80.00(78.50,86.00) | 93.00(91.50,94.00) | 131±15 | 84±12 | 133±16 | 85±12 | 127±16 | 80±12 |
| 中度组 | 187 | 22.30(18.83,26.48)a | 77.00(71.50,81.25)a | 90.00(87.00,93.00)a | 133±14 | 84±11 | 135±15 | 85±12 | 128±16 | 80±12 |
| 重度组 | 203 | 45.60(40.40,63.50)ab | 75.00(65.00,79.00)ab | 90.00(87.00,92.00)a | 135±18a | 86±13 | 136±18 | 87±13 | 130±19ab | 82±14 |
| F(H)值 | 414.811c | 73.117c | 61.436c | 1.522 | 1.823 | 1.222 | 1.272 | 1.640 | 1.006 | |
| P值 | <0.001 | <0.001 | <0.001 | 0.220 | 0.163 | 0.295 | 0.281 | 0.045 | 0.367 |
| 项目 | r(rs)值 | P值 |
|---|---|---|
| AHI | 0.223a | <0.001 |
| LSaO2 | -0.103a | 0.023 |
| MSaO2 | -0.090a | 0.048 |
| BMI | 0.226a | <0.001 |
| 年龄 | -0.098 | 0.032 |
| 性别(男性) | 0.177a | <0.001 |
| 24 hMSBP | 0.126 | 0.008 |
| 24 hMDBP | 0.109 | 0.020 |
Table 3 Correlation analysis of 24-hour urinary sodium excretion with PSG indicators and clinical features in patients with OSA-associated hypertension
| 项目 | r(rs)值 | P值 |
|---|---|---|
| AHI | 0.223a | <0.001 |
| LSaO2 | -0.103a | 0.023 |
| MSaO2 | -0.090a | 0.048 |
| BMI | 0.226a | <0.001 |
| 年龄 | -0.098 | 0.032 |
| 性别(男性) | 0.177a | <0.001 |
| 24 hMSBP | 0.126 | 0.008 |
| 24 hMDBP | 0.109 | 0.020 |
| 项目 | B | SE | β | t值 | P值 | VIF |
|---|---|---|---|---|---|---|
| 常数 | 23.055 | 31.182 | 0.739 | 0.460 | ||
| AHI | 0.419 | 0.141 | 0.138 | 2.964 | 0.003 | 1.144 |
| 24 hMSBP | 0.406 | 0.191 | 0.114 | 2.128 | 0.034 | 1.026 |
| BMI | 2.873 | 0.829 | 0.166 | 3.466 | 0.001 | 1.145 |
| 性别 | 23.580 | 6.641 | 0.160 | 3.551 | <0.001 | 1.009 |
Table 4 Multivariate linear regression analysis of influencing factors for 24-h urinary sodium in patients with OSA-associated hypertension
| 项目 | B | SE | β | t值 | P值 | VIF |
|---|---|---|---|---|---|---|
| 常数 | 23.055 | 31.182 | 0.739 | 0.460 | ||
| AHI | 0.419 | 0.141 | 0.138 | 2.964 | 0.003 | 1.144 |
| 24 hMSBP | 0.406 | 0.191 | 0.114 | 2.128 | 0.034 | 1.026 |
| BMI | 2.873 | 0.829 | 0.166 | 3.466 | 0.001 | 1.145 |
| 性别 | 23.580 | 6.641 | 0.160 | 3.551 | <0.001 | 1.009 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
王云,何燕,刘师节,等. 阻塞性睡眠呼吸暂停低通气综合征与糖脂代谢紊乱的机制研究进展[J]. 中国全科医学,2022,25(2):243-247. DOI:10.12114/j.issn.1007-9572.2021.01.311.
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
国家卫生健康委高血压诊疗研究重点实验室学术委员会,新疆维吾尔自治区人民医院高血压中心. 2023阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识 [J]. 中华高血压杂志,2023,31(12):1142-1155. DOI:10.16439/j.issn.1673-7245.2023.12.003.
|
| [12] |
孙宁玲,牟建军,李玉明. 高血压患者盐摄入量评估和血压管理临床流程专家建议书[J]. 中华高血压杂志,2016,24(8):727-728.
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||